Roche Seeks Diagnostics To Pair With Cancer Drugs In $3 Billion Ventana Bid
Executive Summary
Roche's $3 billion hostile takeover bid for Ventana Medical Systems is aimed at providing the drug and diagnostics giant with platform technology for tissue-based diagnostic tests to pair with targeted cancer drugs, the company says
You may also be interested in...
Pharmacogenomics Draft Guidance Needs Clarification, Industry Tells FDA
Industry is pressing FDA to enhance the utility of its "companion guidance" on pharmacogenomic data submissions as the agency refines the draft document
Pharmacogenomics Draft Guidance Needs Clarification, Industry Tells FDA
Industry is pressing FDA to enhance the utility of its "companion guidance" on pharmacogenomic data submissions as the agency refines the draft document
Roche Diagnostics CEO Is No Ugly Duckling: Schwan Picked To Head Parent Corp.
Roche Diagnostics CEO Severin Schwan will succeed Franz Humer as CEO of Roche, reflecting a two-fold strategy to separate the chairman and CEO roles and to effect a generational management transition, the drug and diagnostics giant announced July 19